News
Press Releases
Pr
Press Release
Seqens confirms the acquisition of CELLforCURE
SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, 2023.
Events and more
01
May 13-17, / New Orleans, LA
//Meet us booth #1047//
The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
02
September 23-26 / Boston, MA
//Meet us booth #70//The 10th CAR-TCR Summit is as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need
03
October 6-8 / Phoenix, AZ
//Exhibit table : McArthur ballroom//The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
04
November 11-12 / London, UK
//Meet us booth #44//
Follow our presentation, November 12 at 11.15 AM
Track 2: Strategies for Cell Therapy Manufacturing
